Table 1 Clinical review for patients with adverse normal tissue reactions to radiotherapy
From: Low levels of ATM in breast cancer patients with clinical radiosensitivity
Patient | Cancer | Sex | ATM% | Age | Reaction | Clinical features |
|---|---|---|---|---|---|---|
1 | Prostate | M | 69 | 64 | A | RTOG4 - treatment terminated at 28 Gy |
2 | Prostate | M | 80 | 72 | L | RTOG3 - Proctitis |
3 | Prostate | M | 90 | 69 | L | RTOG3 - Proctitis |
4 | Prostate | M | 82 | 71 | L | RTOG3 - Proctitis |
5 | Prostate | M | 79 | 60 | L | RTOG3 - Cystitis |
6 | Prostate | M | 80 | 65 | L | RTOG3 - Proctitis |
7 | Cervix | F | 71 | 36 | L | RTOG3 - Urethral stricture |
8 | Cervix | F | 81 | 47 | L | RTOG3 |
9 | Breast | F | 80 | 51 | A | RTOG3 - Moist desquamation |
10*¥∞ | Breast | F | 35 | 64 | A&L | RTOG4 - Familial Treatment terminated at 20 Gy |
11*£¥ | Breast | F | 45 | 54 | A&L | RTOG3 - Moist desquamation; skin atrophy/pigment |
12 | Breast | F | 82 | 57 | L | RTOG3 - Familial |
13*∞£¥ | Breast | F | 8 | 50 | L | RTOG4 - Familial, skin atrophy & fibrosis, necrosis |
14 | Breast | F | 77 | 41 | L | RTOG3 - Fibrosis (skin, subcutaneous tissue & breast) |
15 | Breast | F | 66 | 71 | L | RTOG4 - Familial |
16*£ | Breast | F | 30 | 77 | L | RTOG4 |
17 | Breast | F | 64 | 47 | L | RTOG3 |
18 | Breast | F | 88 | 58 | L | RTOG3 |
19 | Breast | F | 69 | 62 | L | RTOG3 |
20 | Breast | F | 66 | 70 | L | RTOG3 |